Angel Pharmaceuticals Announces Approval of IND Application

/PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been...

Related Keywords

China , Yuqin , Xizang , United States , Peking , Beijing , Zhejiang , Jiaxing , Chinese , American , Angel Pharma , Richarda Miller , Prnewswire Angel Pharmaceuticals Co Ltd , Hisun Pharmaceuticals , Corvus Pharmaceuticals , Angel Pharmaceuticals , Lymphoma Department At Peking University Cancer Hospital , Lymphoma Alliance , Corvus Pharmaceuticals Inc , Nasdaq , American Society Of Hematology , Chinese Society Of Clinical Oncology , Betta Pharmaceuticals , Drug Evaluation , American Society , Song Yuqin , Chinese Society , Clinical Oncology , Anti Lymphoma Alliance , Deputy Director , Lymphoma Department , Peking University Cancer Hospital , Zhejiang Puissance Capital , Angel Pharmaceutical ,